{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:27:42Z","timestamp":1786714062387,"version":"build-2736575974"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS109150"],"award-info":[{"award-number":["R01NS109150"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["RF1NS114128"],"award-info":[{"award-number":["RF1NS114128"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Farber Family Foundation"},{"name":"Aldrich Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-026-02341-8","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:42:55Z","timestamp":1781790175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intrathecal (G4C2)149 delivery in C9orf72-deficient mice yields mild motor dysfunction and ALS\/FTD pathological hallmarks"],"prefix":"10.1186","volume":"14","author":[{"given":"Katelyn A.","family":"Russell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia A.","family":"Shahrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suleyman C.","family":"Akerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Rothstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Trotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigid K.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron R.","family":"Haeusler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"2341_CR1","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1212\/wnl.59.7.1077","volume":"59","author":"C Lomen-Hoerth","year":"2002","unstructured":"Lomen-Hoerth C, Anderson T, Miller B (2002) The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 59:1077\u20131079. https:\/\/doi.org\/10.1212\/wnl.59.7.1077","journal-title":"Neurology"},{"key":"2341_CR2","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1212\/01.wnl.0000172911.39167.b6","volume":"65","author":"GM Ringholz","year":"2005","unstructured":"Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, Schulz PE (2005) Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 65:586\u2013590. https:\/\/doi.org\/10.1212\/01.wnl.0000172911.39167.b6","journal-title":"Neurology"},{"key":"2341_CR3","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1212\/01.wnl.0000277422.11236.2c","volume":"69","author":"MW Wheaton","year":"2007","unstructured":"Wheaton MW, Salamone AR, Mosnik DM, McDonald RO, Appel SH, Schmolck HI, Ringholz GM, Schulz PE (2007) Cognitive impairment in familial ALS. Neurology 69:1411\u20131417. https:\/\/doi.org\/10.1212\/01.wnl.0000277422.11236.2c","journal-title":"Neurology"},{"key":"2341_CR4","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/s0140-6736(16)00737-6","volume":"388","author":"JR Burrell","year":"2016","unstructured":"Burrell JR, Halliday GM, Kril JJ, Ittner LM, Gotz J, Kiernan MC, Hodges JR (2016) The frontotemporal dementia-motor neuron disease continuum. Lancet 388:919\u2013931. https:\/\/doi.org\/10.1016\/s0140-6736(16)00737-6","journal-title":"Lancet"},{"key":"2341_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/21678421.2016.1267768","volume":"18","author":"MJ Strong","year":"2017","unstructured":"Strong MJ, Abrahams S, Goldstein LH, Woolley S, McLaughlin P, Snowden J, Mioshi E, Roberts-South A, Benatar M, Hortob\u00e1Gyi T et al (2017) Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener 18:153\u2013174. https:\/\/doi.org\/10.1080\/21678421.2016.1267768","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2341_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130\u2013133. https:\/\/doi.org\/10.1126\/science.1134108","journal-title":"Science"},{"key":"2341_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.brainres.2016.04.004","volume":"1647","author":"AD Gitler","year":"2016","unstructured":"Gitler AD, Tsuiji H (2016) There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD\/ALS. Brain Res 1647:19\u201329. https:\/\/doi.org\/10.1016\/j.brainres.2016.04.004","journal-title":"Brain Res"},{"key":"2341_CR8","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41582-018-0047-2","volume":"14","author":"R Balendra","year":"2018","unstructured":"Balendra R, Isaacs AM (2018) C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol 14:544\u2013558. https:\/\/doi.org\/10.1038\/s41582-018-0047-2","journal-title":"Nat Rev Neurol"},{"key":"2341_CR9","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41418-018-0060-4","volume":"25","author":"H Chen","year":"2018","unstructured":"Chen H, Kankel MW, Su SC, Han SWS, Ofengeim D (2018) Exploring the genetics and non-cell autonomous mechanisms underlying ALS\/FTLD. Cell Death Differ 25:648\u2013662. https:\/\/doi.org\/10.1038\/s41418-018-0060-4","journal-title":"Cell Death Differ"},{"key":"2341_CR10","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/s0140-6736(10)61156-7","volume":"377","author":"MC Kiernan","year":"2011","unstructured":"Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC (2011) Amyotrophic lateral sclerosis. Lancet 377:942\u2013955. https:\/\/doi.org\/10.1016\/s0140-6736(10)61156-7","journal-title":"Lancet"},{"key":"2341_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature20413","volume":"539","author":"JP Taylor","year":"2016","unstructured":"Taylor JP, Brown RH Jr., Cleveland DW (2016) Decoding ALS: from genes to mechanism. Nature 539:197\u2013206. https:\/\/doi.org\/10.1038\/nature20413","journal-title":"Nature"},{"key":"2341_CR12","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3389\/fnins.2019.00532","volume":"13","author":"AMG Ragagnin","year":"2019","unstructured":"Ragagnin AMG, Shadfar S, Vidal M, Jamali MS, Atkin JD (2019) Motor Neuron Susceptibility in ALS\/FTD. Front Neurosci 13:532. https:\/\/doi.org\/10.3389\/fnins.2019.00532","journal-title":"Front Neurosci"},{"key":"2341_CR13","doi-asserted-by":"publisher","unstructured":"Verma A (2021) Chapter 1: Clinical Manifestation and Management of Amyotrophic Lateral Sclerosis. In: Araki T (ed) Amyotrophic Lateral Sclerosis. Exon. Copyright\u00a9 2021 Exon Publications.) https:\/\/doi.org\/10.36255\/exonpublications.amyotrophiclateralsclerosis.2021.","DOI":"10.36255\/exonpublications.amyotrophiclateralsclerosis.2021"},{"key":"2341_CR14","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1212\/wnl.51.6.1546","volume":"51","author":"D Neary","year":"1998","unstructured":"Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M et al (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51:1546\u20131554. https:\/\/doi.org\/10.1212\/wnl.51.6.1546","journal-title":"Neurology"},{"key":"2341_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/neucas\/7.1.31","volume":"7","author":"JR Hodges","year":"2001","unstructured":"Hodges JR, Miller B (2001) The classification, genetics and neuropathology of frontotemporal dementia. Introduction to the special topic papers: Part I. Neurocase 7:31\u201335. https:\/\/doi.org\/10.1093\/neucas\/7.1.31","journal-title":"Neurocase"},{"key":"2341_CR16","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1093\/brain\/awr195","volume":"134","author":"JR Burrell","year":"2011","unstructured":"Burrell JR, Kiernan MC, Vucic S, Hodges JR (2011) Motor neuron dysfunction in frontotemporal dementia. Brain 134:2582\u20132594. https:\/\/doi.org\/10.1093\/brain\/awr195","journal-title":"Brain"},{"key":"2341_CR17","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","volume":"79","author":"SC Ling","year":"2013","unstructured":"Ling SC, Polymenidou M, Cleveland DW (2013) Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79:416\u2013438. https:\/\/doi.org\/10.1016\/j.neuron.2013.07.033","journal-title":"Neuron"},{"key":"2341_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s40478-017-0480-2","volume":"5","author":"RH Tan","year":"2017","unstructured":"Tan RH, Yang Y, Kim WS, Dobson-Stone C, Kwok JB, Kiernan MC, Halliday GM (2017) Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis. Acta Neuropathol Commun 5:76. https:\/\/doi.org\/10.1186\/s40478-017-0480-2","journal-title":"Acta Neuropathol Commun"},{"key":"2341_CR19","doi-asserted-by":"publisher","first-page":"104351","DOI":"10.1016\/j.drudis.2025.104351","volume":"30","author":"ZZ Chong","year":"2025","unstructured":"Chong ZZ, Souayah N (2025) Pathogenic TDP-43 in amyotrophic lateral sclerosis. Drug Discov Today 30:104351. https:\/\/doi.org\/10.1016\/j.drudis.2025.104351","journal-title":"Drug Discov Today"},{"key":"2341_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245\u2013256. https:\/\/doi.org\/10.1016\/j.neuron.2011.09.011","journal-title":"Neuron"},{"key":"2341_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/s1474-4422(11)70261-7","volume":"11","author":"I Gijselinck","year":"2012","unstructured":"Gijselinck I, Van Langenhove T, van der Zee J, Sleegers K, Philtjens S, Kleinberger G, Janssens J, Bettens K, Van Cauwenberghe C, Pereson S et al (2012) A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol 11:54\u201365. https:\/\/doi.org\/10.1016\/s1474-4422(11)70261-7","journal-title":"Lancet Neurol"},{"key":"2341_CR22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00401-015-1445-9","volume":"130","author":"E Suh","year":"2015","unstructured":"Suh E, Lee EB, Neal D, Wood EM, Toledo JB, Rennert L, Irwin DJ, McMillan CT, Krock B, Elman LB et al (2015) Semi-automated quantification of C9orf72 expansion size reveals inverse correlation between hexanucleotide repeat number and disease duration in frontotemporal degeneration. Acta Neuropathol 130:363\u2013372. https:\/\/doi.org\/10.1007\/s00401-015-1445-9","journal-title":"Acta Neuropathol"},{"key":"2341_CR23","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1093\/hmg\/ddv064","volume":"24","author":"A Nordin","year":"2015","unstructured":"Nordin A, Akimoto C, Wuolikainen A, Alstermark H, Jonsson P, Birve A, Marklund SL, Graffmo KS, Forsberg K, Brannstrom T, Andersen PM (2015) Extensive size variability of the GGGGCC expansion in C9orf72 in both neuronal and non-neuronal tissues in 18 patients with ALS or FTD. Hum Mol Genet 24:3133\u20133142. https:\/\/doi.org\/10.1093\/hmg\/ddv064","journal-title":"Hum Mol Genet"},{"key":"2341_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neulet.2016.09.007","volume":"636","author":"X Wen","year":"2017","unstructured":"Wen X, Westergard T, Pasinelli P, Trotti D (2017) Pathogenic determinants and mechanisms of ALS\/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene. Neurosci Lett 636:16\u201326. https:\/\/doi.org\/10.1016\/j.neulet.2016.09.007","journal-title":"Neurosci Lett"},{"key":"2341_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","volume":"72","author":"AE Renton","year":"2011","unstructured":"Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72:257\u2013268. https:\/\/doi.org\/10.1016\/j.neuron.2011.09.010","journal-title":"Neuron"},{"key":"2341_CR26","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/s1474-4422(12)70043-1","volume":"11","author":"E Majounie","year":"2012","unstructured":"Majounie E, Renton AE, Mok K, Dopper EG, Waite A, Rollinson S, Chio A, Restagno G, Nicolaou N, Simon-Sanchez J et al (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 11:323\u2013330. https:\/\/doi.org\/10.1016\/s1474-4422(12)70043-1","journal-title":"Lancet Neurol"},{"key":"2341_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nn.3584","volume":"17","author":"AE Renton","year":"2014","unstructured":"Renton AE, Chio A, Traynor BJ (2014) State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 17:17\u201323. https:\/\/doi.org\/10.1038\/nn.3584","journal-title":"Nat Neurosci"},{"key":"2341_CR28","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1136\/jnnp-2017-315995","volume":"88","author":"MR Turner","year":"2017","unstructured":"Turner MR, Al-Chalabi A, Chio A, Hardiman O, Kiernan MC, Rohrer JD, Rowe J, Seeley W, Talbot K (2017) Genetic screening in sporadic ALS and FTD. J Neurol Neurosurg Psychiatry 88:1042\u20131044. https:\/\/doi.org\/10.1136\/jnnp-2017-315995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2341_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-020-0619-5","author":"Q Zhu","year":"2020","unstructured":"Zhu Q, Jiang J, Gendron TF, McAlonis-Downes M, Jiang L, Taylor A, Diaz Garcia S, Ghosh Dastidar S, Rodriguez MJ, King P et al (2020) Reduced C9ORF72 function exacerbates gain of toxicity from ALS\/FTD-causing repeat expansion in C9orf72. Nat Neurosci. https:\/\/doi.org\/10.1038\/s41593-020-0619-5","journal-title":"Nat Neurosci"},{"key":"2341_CR30","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1001\/archneur.1990.00530110068019","volume":"47","author":"JI Engelhardt","year":"1990","unstructured":"Engelhardt JI, Appel SH (1990) IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Arch Neurol 47:1210\u20131216. https:\/\/doi.org\/10.1001\/archneur.1990.00530110068019","journal-title":"Arch Neurol"},{"key":"2341_CR31","first-page":"691","volume":"140","author":"T Kawamata","year":"1992","unstructured":"Kawamata T, Akiyama H, Yamada T, McGeer PL (1992) Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 140:691\u2013707","journal-title":"Am J Pathol"},{"key":"2341_CR32","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/ana.20332","volume":"56","author":"A Cagnin","year":"2004","unstructured":"Cagnin A, Rossor M, Sampson EL, Mackinnon T, Banati RB (2004) In vivo detection of microglial activation in frontotemporal dementia. Ann Neurol 56:894\u2013897. https:\/\/doi.org\/10.1002\/ana.20332","journal-title":"Ann Neurol"},{"key":"2341_CR33","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.nbd.2003.12.012","volume":"15","author":"MR Turner","year":"2004","unstructured":"Turner MR, Cagnin A, Turkheimer FE, Miller CC, Shaw CE, Brooks DJ, Leigh PN, Banati RB (2004) Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11\u00a0C](R)-PK11195 positron emission tomography study. Neurobiol Dis 15:601\u2013609. https:\/\/doi.org\/10.1016\/j.nbd.2003.12.012","journal-title":"Neurobiol Dis"},{"key":"2341_CR34","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.bbadis.2006.03.001","volume":"1762","author":"K Moisse","year":"2006","unstructured":"Moisse K, Strong MJ (2006) Innate immunity in amyotrophic lateral sclerosis. Biochim Biophys Acta 1762:1083\u20131093. https:\/\/doi.org\/10.1016\/j.bbadis.2006.03.001","journal-title":"Biochim Biophys Acta"},{"key":"2341_CR35","doi-asserted-by":"publisher","first-page":"e39216","DOI":"10.1371\/journal.pone.0039216","volume":"7","author":"J Brettschneider","year":"2012","unstructured":"Brettschneider J, Toledo JB, Van Deerlin VM, Elman L, McCluskey L, Lee VM, Trojanowski JQ (2012) Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis. PLoS ONE 7:e39216. https:\/\/doi.org\/10.1371\/journal.pone.0039216","journal-title":"PLoS ONE"},{"key":"2341_CR36","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00401-011-0932-x","volume":"123","author":"J Brettschneider","year":"2012","unstructured":"Brettschneider J, Libon DJ, Toledo JB, Xie SX, McCluskey L, Elman L, Geser F, Lee VM, Grossman M, Trojanowski JQ (2012) Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis. Acta Neuropathol 123:395\u2013407. https:\/\/doi.org\/10.1007\/s00401-011-0932-x","journal-title":"Acta Neuropathol"},{"key":"2341_CR37","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.nicl.2015.01.009","volume":"7","author":"NR Zurcher","year":"2015","unstructured":"Zurcher NR, Loggia ML, Lawson R, Chonde DB, Izquierdo-Garcia D, Yasek JE, Akeju O, Catana C, Rosen BR, Cudkowicz ME et al (2015) Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [(11)C]-PBR28. Neuroimage Clin 7:409\u2013414. https:\/\/doi.org\/10.1016\/j.nicl.2015.01.009","journal-title":"Neuroimage Clin"},{"key":"2341_CR38","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1212\/wnl.0000000000003427","volume":"87","author":"MJ Alshikho","year":"2016","unstructured":"Alshikho MJ, Zurcher NR, Loggia ML, Cernasov P, Chonde DB, Izquierdo Garcia D, Yasek JE, Akeju O, Catana C, Rosen BR et al (2016) Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis. Neurology 87:2554\u20132561. https:\/\/doi.org\/10.1212\/wnl.0000000000003427","journal-title":"Neurology"},{"key":"2341_CR39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.15252\/emmm.201708202","volume":"10","author":"ME Umoh","year":"2018","unstructured":"Umoh ME, Dammer EB, Dai J, Duong DM, Lah JJ, Levey AI, Gearing M, Glass JD, Seyfried NT (2018) A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain. EMBO Mol Med 10:48\u201362. https:\/\/doi.org\/10.15252\/emmm.201708202","journal-title":"EMBO Mol Med"},{"key":"2341_CR40","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1126\/science.aaf1064","volume":"351","author":"JG O\u2019Rourke","year":"2016","unstructured":"O\u2019Rourke JG, Bogdanik L, Y\u00e1\u00f1ez A, Lall D, Wolf AJ, Muhammad AK, Ho R, Carmona S, Vit JP, Zarrow J et al (2016) C9orf72 is required for proper macrophage and microglial function in mice. Science 351:1324\u20131329. https:\/\/doi.org\/10.1126\/science.aaf1064","journal-title":"Science"},{"key":"2341_CR41","doi-asserted-by":"publisher","first-page":"347ra393","DOI":"10.1126\/scitranslmed.aaf6038","volume":"8","author":"A Burberry","year":"2016","unstructured":"Burberry A, Suzuki N, Wang JY, Moccia R, Mordes DA, Stewart MH, Suzuki-Uematsu S, Ghosh S, Singh A, Merkle FT et al (2016) Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease. Sci Transl Med 8:347ra393. https:\/\/doi.org\/10.1126\/scitranslmed.aaf6038","journal-title":"Sci Transl Med"},{"key":"2341_CR42","doi-asserted-by":"publisher","first-page":"23204","DOI":"10.1038\/srep23204","volume":"6","author":"A Atanasio","year":"2016","unstructured":"Atanasio A, Decman V, White D, Ramos M, Ikiz B, Lee HC, Siao CJ, Brydges S, LaRosa E, Bai Y et al (2016) C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice. Sci Rep 6:23204. https:\/\/doi.org\/10.1038\/srep23204","journal-title":"Sci Rep"},{"key":"2341_CR43","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1126\/science.aaa9344","volume":"348","author":"J Chew","year":"2015","unstructured":"Chew J, Gendron TF, Prudencio M, Sasaguri H, Zhang YJ, Castanedes-Casey M, Lee CW, Jansen-West K, Kurti A, Murray ME et al (2015) Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits. Science 348:1151\u20131154. https:\/\/doi.org\/10.1126\/science.aaa9344","journal-title":"Science"},{"key":"2341_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13024-019-0310-z","volume":"14","author":"J Chew","year":"2019","unstructured":"Chew J, Cook C, Gendron TF, Jansen-West K, Del Rosso G, Daughrity LM, Castanedes-Casey M, Kurti A, Stankowski JN, Disney MD et al (2019) Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy. Mol Neurodegener 14:9. https:\/\/doi.org\/10.1186\/s13024-019-0310-z","journal-title":"Mol Neurodegener"},{"key":"2341_CR45","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s40478-024-01911-y","volume":"12","author":"EG Thompson","year":"2024","unstructured":"Thompson EG, Spead O, Akerman SC, Curcio C, Zaepfel BL, Kent ER, Philips T, Vijayakumar BG, Zacco A, Zhou W et al (2024) A robust evaluation of TDP-43, poly GP, cellular pathology and behavior in an AAV-C9ORF72 (G(4)C(2))(66) mouse model. Acta Neuropathol Commun 12:203. https:\/\/doi.org\/10.1186\/s40478-024-01911-y","journal-title":"Acta Neuropathol Commun"},{"key":"2341_CR46","unstructured":"In Vivo Capabilities Case Study The AAV9-(G4C2)149 Model for ALS Going Beyond the Baseline Phenotypes [Tech Spec Sheet]. The Jackson Laboratory. https:\/\/resources.jax.org\/fact-sheets\/c9orf72-tech-spec-sheet"},{"key":"2341_CR47","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.neuron.2016.04.006","volume":"90","author":"J Jiang","year":"2016","unstructured":"Jiang J, Zhu Q, Gendron TF, Saberi S, McAlonis-Downes M, Seelman A, Stauffer JE, Jafar-Nejad P, Drenner K, Schulte D et al (2016) Gain of Toxicity from ALS\/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs. Neuron 90:535\u2013550. https:\/\/doi.org\/10.1016\/j.neuron.2016.04.006","journal-title":"Neuron"},{"key":"2341_CR48","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/sj.gt.3300931","volume":"6","author":"SS Elliger","year":"1999","unstructured":"Elliger SS, Elliger CA, Aguilar CP, Raju NR, Watson GL (1999) Elimination of lysosomal storage in brains of MPS VII mice treated by intrathecal administration of an adeno-associated virus vector. Gene Ther 6:1175\u20131178. https:\/\/doi.org\/10.1038\/sj.gt.3300931","journal-title":"Gene Ther"},{"key":"2341_CR49","doi-asserted-by":"publisher","first-page":"9945","DOI":"10.1523\/jneurosci.1802-11.2011","volume":"31","author":"AS Reddy","year":"2011","unstructured":"Reddy AS, Kim JH, Hawkins-Salsbury JA, Macauley SL, Tracy ET, Vogler CA, Han X, Song SK, Wozniak DF, Fowler SC et al (2011) Bone marrow transplantation augments the effect of brain- and spinal cord-directed adeno-associated virus 2\/5 gene therapy by altering inflammation in the murine model of globoid-cell leukodystrophy. J Neurosci 31:9945\u20139957. https:\/\/doi.org\/10.1523\/jneurosci.1802-11.2011","journal-title":"J Neurosci"},{"key":"2341_CR50","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/mt.2014.180","volume":"23","author":"JI Ayers","year":"2015","unstructured":"Ayers JI, Fromholt S, Sinyavskaya O, Siemienski Z, Rosario AM, Li A, Crosby KW, Cruz PE, DiNunno NM, Janus C et al (2015) Widespread and efficient transduction of spinal cord and brain following neonatal AAV injection and potential disease modifying effect in ALS mice. Mol Ther 23:53\u201362. https:\/\/doi.org\/10.1038\/mt.2014.180","journal-title":"Mol Ther"},{"key":"2341_CR51","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/jnr.23882","volume":"94","author":"S Karumuthil-Melethil","year":"2016","unstructured":"Karumuthil-Melethil S, Marshall MS, Heindel C, Jakubauskas B, Bongarzone ER, Gray SJ (2016) Intrathecal administration of AAV\/GALC vectors in 10-11-day-old twitcher mice improves survival and is enhanced by bone marrow transplant. J Neurosci Res 94:1138\u20131151. https:\/\/doi.org\/10.1002\/jnr.23882","journal-title":"J Neurosci Res"},{"key":"2341_CR52","doi-asserted-by":"publisher","first-page":"E5920","DOI":"10.1073\/pnas.1701832114","volume":"114","author":"C Shyng","year":"2017","unstructured":"Shyng C, Nelvagal HR, Dearborn JT, Tyynel\u00e4 J, Schmidt RE, Sands MS, Cooper JD (2017) Synergistic effects of treating the spinal cord and brain in CLN1 disease. Proc Natl Acad Sci U S A 114:E5920\u2013e5929. https:\/\/doi.org\/10.1073\/pnas.1701832114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2341_CR53","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41434-024-00498-2","volume":"32","author":"IT Garza","year":"2025","unstructured":"Garza IT, Eller MM, Holmes SK, Schackmuth MK, Bailey RM (2025) Expression and distribution of rAAV9 intrathecally administered in juvenile to adolescent mice. Gene Ther 32:189\u2013196. https:\/\/doi.org\/10.1038\/s41434-024-00498-2","journal-title":"Gene Ther"},{"key":"2341_CR54","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/s41593-021-00827-3","volume":"24","author":"M Van Alstyne","year":"2021","unstructured":"Van Alstyne M, Tattoli I, Delestr\u00e9e N, Recinos Y, Workman E, Shihabuddin LS, Zhang C, Mentis GZ, Pellizzoni L (2021) Gain of toxic function by long-term AAV9-mediated SMN overexpression in the sensorimotor circuit. Nat Neurosci 24:930\u2013940. https:\/\/doi.org\/10.1038\/s41593-021-00827-3","journal-title":"Nat Neurosci"},{"key":"2341_CR55","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/glia.23710","volume":"68","author":"MK Jha","year":"2020","unstructured":"Jha MK, Lee Y, Russell KA, Yang F, Dastgheyb RM, Deme P, Ament XH, Chen W, Liu Y, Guan Y et al (2020) Monocarboxylate transporter 1 in Schwann cells contributes to maintenance of sensory nerve myelination during aging. Glia 68:161\u2013177. https:\/\/doi.org\/10.1002\/glia.23710","journal-title":"Glia"},{"key":"2341_CR56","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.1038\/s41598-022-09593-z","volume":"12","author":"BM Verdone","year":"2022","unstructured":"Verdone BM, Cicardi ME, Wen X, Sriramoji S, Russell K, Markandaiah SS, Jensen BK, Krishnamurthy K, Haeusler AR, Pasinelli P, Trotti D (2022) A mouse model with widespread expression of the C9orf72-linked glycine-arginine dipeptide displays non-lethal ALS\/FTD-like phenotypes. Sci Rep 12:5644. https:\/\/doi.org\/10.1038\/s41598-022-09593-z","journal-title":"Sci Rep"},{"key":"2341_CR57","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.neuroscience.2015.11.018","volume":"312","author":"C Tallon","year":"2016","unstructured":"Tallon C, Russell KA, Sakhalkar S, Andrapallayal N, Farah MH (2016) Length-dependent axo-terminal degeneration at the neuromuscular synapses of type II muscle in SOD1 mice. Neuroscience 312:179\u2013189. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.11.018","journal-title":"Neuroscience"},{"key":"2341_CR58","unstructured":"DigiGait \u2014 Indices (2015) Mouse Specifics Inc. https:\/\/www.ibric.org\/bric\/biomarket\/product.do?mode=download&articleNo=9976171&attachNo=1324905"},{"key":"2341_CR59","doi-asserted-by":"publisher","first-page":"21510","DOI":"10.1073\/pnas.1211577110","volume":"109","author":"M Prudencio","year":"2012","unstructured":"Prudencio M, Jansen-West KR, Lee WC, Gendron TF, Zhang YJ, Xu YF, Gass J, Stuani C, Stetler C, Rademakers R et al (2012) Misregulation of human sortilin splicing leads to the generation of a nonfunctional progranulin receptor. Proc Natl Acad Sci U S A 109:21510\u201321515. https:\/\/doi.org\/10.1073\/pnas.1211577110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2341_CR60","doi-asserted-by":"publisher","unstructured":"Necarsulmer JC, Simon JM, Evangelista BA, Chen Y, Tian X, Nafees S, Marquez AB, Jiang H, Wang P, Ajit D et al (2023) RNA-binding deficient TDP-43 drives cognitive decline in a mouse model of TDP-43 proteinopathy. Elife 12. https:\/\/doi.org\/10.7554\/eLife.85921","DOI":"10.7554\/eLife.85921"},{"key":"2341_CR61","doi-asserted-by":"publisher","first-page":"eadv3301","DOI":"10.1126\/science.adv3301","volume":"392","author":"KE Copley","year":"2026","unstructured":"Copley KE, Mauna JC, Danielson HL, Chen Q, Ozguney B, Ngo M, Xie L, Smirnov A, Davis M, Mayne L et al (2026) Short RNA chaperones promote aggregation-resistant TDP-43 conformers to mitigate neurodegeneration. Science 392:eadv3301. https:\/\/doi.org\/10.1126\/science.adv3301","journal-title":"Science"},{"key":"2341_CR62","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00401-014-1336-5","volume":"128","author":"YJ Zhang","year":"2014","unstructured":"Zhang YJ, Jansen-West K, Xu YF, Gendron TF, Bieniek KF, Lin WL, Sasaguri H, Caulfield T, Hubbard J, Daughrity L et al (2014) Aggregation-prone c9FTD\/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress. Acta Neuropathol 128:505\u2013524. https:\/\/doi.org\/10.1007\/s00401-014-1336-5","journal-title":"Acta Neuropathol"},{"key":"2341_CR63","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J Roy Stat Soc: Ser B (Methodol) 57:289\u2013300. https:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"key":"2341_CR64","doi-asserted-by":"publisher","first-page":"40769","DOI":"10.1038\/s41598-025-24664-7","volume":"15","author":"M Straczkiewicz","year":"2025","unstructured":"Straczkiewicz M, Burke KM, Carney KT, Calcagno N, Mandepudi S, Premasiri A, Vieira FG, Berry JD (2025) Analytical and clinical validation of step counting method in people living with amyotrophic lateral sclerosis. Sci Rep 15:40769. https:\/\/doi.org\/10.1038\/s41598-025-24664-7","journal-title":"Sci Rep"},{"key":"2341_CR65","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/mus.20228","volume":"32","author":"CM Wooley","year":"2005","unstructured":"Wooley CM, Sher RB, Kale A, Frankel WN, Cox GA, Seburn KL (2005) Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle Nerve 32:43\u201350. https:\/\/doi.org\/10.1002\/mus.20228","journal-title":"Muscle Nerve"},{"key":"2341_CR66","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.brainres.2011.06.033","volume":"1406","author":"R Mancuso","year":"2011","unstructured":"Mancuso R, Oliv\u00e1n S, Osta R, Navarro X (2011) Evolution of gait abnormalities in SOD1(G93A) transgenic mice. Brain Res 1406:65\u201373. https:\/\/doi.org\/10.1016\/j.brainres.2011.06.033","journal-title":"Brain Res"},{"key":"2341_CR67","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/nan.12284","volume":"42","author":"LJ Schipper","year":"2016","unstructured":"Schipper LJ, Raaphorst J, Aronica E, Baas F, de Haan R, de Visser M, Troost D (2016) Prevalence of brain and spinal cord inclusions, including dipeptide repeat proteins, in patients with the C9ORF72 hexanucleotide repeat expansion: a systematic neuropathological review. Neuropathol Appl Neurobiol 42:547\u2013560. https:\/\/doi.org\/10.1111\/nan.12284","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2341_CR68","doi-asserted-by":"publisher","first-page":"637548","DOI":"10.3389\/fncel.2021.637548","volume":"15","author":"A Schmitz","year":"2021","unstructured":"Schmitz A, Pinheiro Marques J, Oertig I, Maharjan N, Saxena S (2021) Emerging Perspectives on Dipeptide Repeat Proteins in C9ORF72 ALS\/FTD. Front Cell Neurosci 15:637548. https:\/\/doi.org\/10.3389\/fncel.2021.637548","journal-title":"Front Cell Neurosci"},{"key":"2341_CR69","unstructured":"Allen Institute for Brain Science (2011) Allen Reference Atlas \u2013 Mouse Brain [Brain Atlas]. atlas.brain-map.org"},{"key":"2341_CR70","doi-asserted-by":"publisher","unstructured":"Suk TR, Rousseaux MWC (2020) The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol Neurodegener 15. https:\/\/doi.org\/10.1186\/s13024-020-00397-1","DOI":"10.1186\/s13024-020-00397-1"},{"key":"2341_CR71","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00401-013-1181-y","volume":"126","author":"IR Mackenzie","year":"2013","unstructured":"Mackenzie IR, Arzberger T, Kremmer E, Troost D, Lorenzl S, Mori K, Weng SM, Haass C, Kretzschmar HA, Edbauer D, Neumann M (2013) Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations. Acta Neuropathol 126:859\u2013879. https:\/\/doi.org\/10.1007\/s00401-013-1181-y","journal-title":"Acta Neuropathol"},{"key":"2341_CR72","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nm.4490","volume":"24","author":"Y Shi","year":"2018","unstructured":"Shi Y, Lin S, Staats KA, Li Y, Chang WH, Hung ST, Hendricks E, Linares GR, Wang Y, Son EY et al (2018) Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS\/FTD human induced motor neurons. Nat Med 24:313\u2013325. https:\/\/doi.org\/10.1038\/nm.4490","journal-title":"Nat Med"},{"key":"2341_CR73","doi-asserted-by":"publisher","first-page":"e100574","DOI":"10.15252\/embj.2018100574","volume":"39","author":"M Boivin","year":"2020","unstructured":"Boivin M, Pfister V, Gaucherot A, Ruffenach F, Negroni L, Sellier C, Charlet-Berguerand N (2020) Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders. Embo j 39:e100574. https:\/\/doi.org\/10.15252\/embj.2018100574","journal-title":"Embo j"},{"key":"2341_CR74","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1007\/s12035-016-9850-1","volume":"54","author":"N Maharjan","year":"2017","unstructured":"Maharjan N, K\u00fcnzli C, Buthey K, Saxena S (2017) C9ORF72 Regulates Stress Granule Formation and Its Deficiency Impairs Stress Granule Assembly, Hypersensitizing Cells to Stress. Mol Neurobiol 54:3062\u20133077. https:\/\/doi.org\/10.1007\/s12035-016-9850-1","journal-title":"Mol Neurobiol"},{"key":"2341_CR75","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.stemcr.2020.01.010","volume":"14","author":"M Abo-Rady","year":"2020","unstructured":"Abo-Rady M, Kalmbach N, Pal A, Schludi C, Janosch A, Richter T, Freitag P, Bickle M, Kahlert AK, Petri S et al (2020) Knocking out C9ORF72 Exacerbates Axonal Trafficking Defects Associated with Hexanucleotide Repeat Expansion and Reduces Levels of Heat Shock Proteins. Stem Cell Rep 14:390\u2013405. https:\/\/doi.org\/10.1016\/j.stemcr.2020.01.010","journal-title":"Stem Cell Rep"},{"key":"2341_CR76","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/hmg\/ddac271","volume":"32","author":"L Ma","year":"2023","unstructured":"Ma L, Liang C, Wang J, Chang Q, Wang Y, Zhang W, Du Y, Sadan J, Chen JF (2023) Reversing lysosome-ribosome circuit dysregulation mitigates C9FTD\/ALS neurodegeneration and behaviors. Hum Mol Genet 32:1252\u20131265. https:\/\/doi.org\/10.1093\/hmg\/ddac271","journal-title":"Hum Mol Genet"},{"key":"2341_CR77","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cnp.2024.04.002","volume":"9","author":"PE Barkhaus","year":"2024","unstructured":"Barkhaus PE, Nandedkar SD, de Carvalho M, Swash M, St\u00e5lberg EV (2024) Revisiting the compound muscle action potential (CMAP). Clin Neurophysiol Pract 9:176\u2013200. https:\/\/doi.org\/10.1016\/j.cnp.2024.04.002","journal-title":"Clin Neurophysiol Pract"},{"key":"2341_CR78","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1743-0003-2-20","volume":"2","author":"I Amende","year":"2005","unstructured":"Amende I, Kale A, McCue S, Glazier S, Morgan JP, Hampton TG (2005) Gait dynamics in mouse models of Parkinson\u2019s disease and Huntington\u2019s disease. J Neuroeng Rehabil 2:20. https:\/\/doi.org\/10.1186\/1743-0003-2-20","journal-title":"J Neuroeng Rehabil"},{"key":"2341_CR79","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1038\/s41467-019-10956-w","volume":"10","author":"Z Hao","year":"2019","unstructured":"Hao Z, Liu L, Tao Z, Wang R, Ren H, Sun H, Lin Z, Zhang Z, Mu C, Zhou J, Wang G (2019) Motor dysfunction and neurodegeneration in a C9orf72 mouse line expressing poly-PR. Nat Commun 10:2906. https:\/\/doi.org\/10.1038\/s41467-019-10956-w","journal-title":"Nat Commun"},{"key":"2341_CR80","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neulet.2016.08.007","volume":"631","author":"M Przybyla","year":"2016","unstructured":"Przybyla M, Stevens CH, van der Hoven J, Harasta A, Bi M, Ittner A, van Hummel A, Hodges JR, Piguet O, Karl T et al (2016) Disinhibition-like behavior in a P301S mutant tau transgenic mouse model of frontotemporal dementia. Neurosci Lett 631:24\u201329. https:\/\/doi.org\/10.1016\/j.neulet.2016.08.007","journal-title":"Neurosci Lett"},{"key":"2341_CR81","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00401-015-1486-0","volume":"130","author":"YD Ke","year":"2015","unstructured":"Ke YD, van Hummel A, Stevens CH, Gladbach A, Ippati S, Bi M, Lee WS, Kr\u00fcger S, van der Hoven J, Volkerling A et al (2015) Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS. Acta Neuropathol 130:661\u2013678. https:\/\/doi.org\/10.1007\/s00401-015-1486-0","journal-title":"Acta Neuropathol"},{"key":"2341_CR82","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3389\/fnagi.2016.00310","volume":"8","author":"JA Alfieri","year":"2016","unstructured":"Alfieri JA, Silva PR, Igaz LM (2016) Early Cognitive\/Social Deficits and Late Motor Phenotype in Conditional Wild-Type TDP-43 Transgenic Mice. Front Aging Neurosci 8:310. https:\/\/doi.org\/10.3389\/fnagi.2016.00310","journal-title":"Front Aging Neurosci"},{"key":"2341_CR83","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1038\/s41467-021-23187-9","volume":"12","author":"J Scekic-Zahirovic","year":"2021","unstructured":"Scekic-Zahirovic J, Sanjuan-Ruiz I, Kan V, Megat S, De Rossi P, Dieterl\u00e9 S, Cassel R, Jamet M, Kessler P, Wiesner D et al (2021) Cytoplasmic FUS triggers early behavioral alterations linked to cortical neuronal hyperactivity and inhibitory synaptic defects. Nat Commun 12:3028. https:\/\/doi.org\/10.1038\/s41467-021-23187-9","journal-title":"Nat Commun"},{"key":"2341_CR84","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/WAD.0b013e318265bbc9","volume":"27","author":"C O\u2019Callaghan","year":"2013","unstructured":"O\u2019Callaghan C, Hodges JR, Hornberger M (2013) Inhibitory dysfunction in frontotemporal dementia: a review. Alzheimer Dis Assoc Disord 27:102\u2013108. https:\/\/doi.org\/10.1097\/WAD.0b013e318265bbc9","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2341_CR85","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/neup.12290","volume":"36","author":"T Miki","year":"2016","unstructured":"Miki T, Yokota O, Ishizu H, Kuroda S, Oshima E, Terada S, Yamada N (2016) Behavioral variant of frontotemporal dementia: Fundamental clinical issues associated with prediction of pathological bases. Neuropathology 36:388\u2013404. https:\/\/doi.org\/10.1111\/neup.12290","journal-title":"Neuropathology"},{"key":"2341_CR86","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1080\/14712598.2022.2060737","volume":"22","author":"TK Kishimoto","year":"2022","unstructured":"Kishimoto TK, Samulski RJ (2022) Addressing high dose AAV toxicity - \u2018one and done\u2019 or \u2018slower and lower\u2019? Expert Opin Biol Ther 22:1067\u20131071. https:\/\/doi.org\/10.1080\/14712598.2022.2060737","journal-title":"Expert Opin Biol Ther"},{"key":"2341_CR87","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41434-023-00405-1","volume":"32","author":"D Stone","year":"2025","unstructured":"Stone D, Aubert M, Jerome KR (2025) Adeno-associated virus vectors and neurotoxicity-lessons from preclinical and human studies. Gene Ther 32:60\u201373. https:\/\/doi.org\/10.1038\/s41434-023-00405-1","journal-title":"Gene Ther"},{"key":"2341_CR88","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1016\/j.ymthe.2025.03.037","volume":"33","author":"AM Keeler","year":"2025","unstructured":"Keeler AM, Zhan W, Ram S, Fitzgerald KA, Gao G (2025) The curious case of AAV immunology. Mol Ther 33:1946\u20131965. https:\/\/doi.org\/10.1016\/j.ymthe.2025.03.037","journal-title":"Mol Ther"},{"key":"2341_CR89","doi-asserted-by":"publisher","unstructured":"Mole AJ, Sander CF, Parmar AR, Williams AJ, Azzouz M, Hautbergue GM, Shaw PJ, Ferraiuolo L, Mead RJ (2025) Comparison of AAV9-driven motor neuron transduction following different CNS-directed delivery methods in mice. bioRxiv, 2025.2007.2001.662642. https:\/\/doi.org\/10.1101\/2025.07.01.662642","DOI":"10.1101\/2025.07.01.662642"},{"key":"2341_CR90","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fnana.2014.00042","volume":"8","author":"DJ Schuster","year":"2014","unstructured":"Schuster DJ, Dykstra JA, Riedl MS, Kitto KF, Belur LR, McIvor RS, Elde RP, Fairbanks CA, Vulchanova L (2014) Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse. Front Neuroanat 8:42. https:\/\/doi.org\/10.3389\/fnana.2014.00042","journal-title":"Front Neuroanat"},{"key":"2341_CR91","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/nn.4593","volume":"20","author":"KY Chan","year":"2017","unstructured":"Chan KY, Jang MJ, Yoo BB, Greenbaum A, Ravi N, Wu WL, Sanchez-Guardado L, Lois C, Mazmanian SK, Deverman BE, Gradinaru V (2017) Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat Neurosci 20:1172\u20131179. https:\/\/doi.org\/10.1038\/nn.4593","journal-title":"Nat Neurosci"},{"key":"2341_CR92","doi-asserted-by":"publisher","unstructured":"Hordeaux J, Buza EL, Jeffrey B, Song C, Jahan T, Yuan Y, Zhu Y, Bell P, Li M, Chichester JA et al (2020) MicroRNA-mediated inhibition of transgene expression reduces dorsal root ganglion toxicity by AAV vectors in primates. Sci Transl Med 12. https:\/\/doi.org\/10.1126\/scitranslmed.aba9188","DOI":"10.1126\/scitranslmed.aba9188"},{"key":"2341_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-018-1921-0","volume":"137","author":"SC Vatsavayai","year":"2019","unstructured":"Vatsavayai SC, Nana AL, Yokoyama JS, Seeley WW (2019) C9orf72-FTD\/ALS pathogenesis: evidence from human neuropathological studies. Acta Neuropathol 137:1\u201326. https:\/\/doi.org\/10.1007\/s00401-018-1921-0","journal-title":"Acta Neuropathol"},{"key":"2341_CR94","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1093\/brain\/aww250","volume":"139","author":"SC Vatsavayai","year":"2016","unstructured":"Vatsavayai SC, Yoon SJ, Gardner RC, Gendron TF, Vargas JN, Trujillo A, Pribadi M, Phillips JJ, Gaus SE, Hixson JD et al (2016) Timing and significance of pathological features in C9orf72 expansion-associated frontotemporal dementia. Brain 139:3202\u20133216. https:\/\/doi.org\/10.1093\/brain\/aww250","journal-title":"Brain"},{"key":"2341_CR95","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/nan.12178","volume":"41","author":"A Baborie","year":"2015","unstructured":"Baborie A, Griffiths TD, Jaros E, Perry R, McKeith IG, Burn DJ, Masuda-Suzukake M, Hasegawa M, Rollinson S, Pickering-Brown S et al (2015) Accumulation of dipeptide repeat proteins predates that of TDP-43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene. Neuropathol Appl Neurobiol 41:601\u2013612. https:\/\/doi.org\/10.1111\/nan.12178","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2341_CR96","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00401-014-1245-7","volume":"127","author":"M Proudfoot","year":"2014","unstructured":"Proudfoot M, Gutowski NJ, Edbauer D, Hilton DA, Stephens M, Rankin J, Mackenzie IR (2014) Early dipeptide repeat pathology in a frontotemporal dementia kindred with C9ORF72 mutation and intellectual disability. Acta Neuropathol 127:451\u2013458. https:\/\/doi.org\/10.1007\/s00401-014-1245-7","journal-title":"Acta Neuropathol"},{"key":"2341_CR97","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41591-023-02788-5","volume":"30","author":"KE Irwin","year":"2024","unstructured":"Irwin KE, Jasin P, Braunstein KE, Sinha IR, Garret MA, Bowden KD, Chang K, Troncoso JC, Moghekar A, Oh ES et al (2024) A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD. Nat Med 30:382\u2013393. https:\/\/doi.org\/10.1038\/s41591-023-02788-5","journal-title":"Nat Med"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-026-02341-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02341-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02341-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T12:32:04Z","timestamp":1786710724000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-026-02341-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":97,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2341"],"URL":"https:\/\/doi.org\/10.1186\/s40478-026-02341-8","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All of the authors have read and approved the manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"167"}}